Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Johnson

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Biochemical and Biophysical Research Communications|January 8, 1999
Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding proteinK N Kumar, P S Johnson, X Chen, et al.
The Journal of Biological Chemistry|August 12, 1994
-mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activityC K Surratt, P S Johnson, A Moriwaki, et al.
FEBS Letters|July 4, 1994
cDNA cloning of an orphan opiate receptor gene family member and its splice variantJ B Wang, P S Johnson, Y Imai, et al.
Brain Research. Molecular Brain Research|August 5, 2000
Control of mu opioid receptor expression by modification of cDNA 5'- and 3'-noncoding regionsC Zöllner, P S Johnson, J Bei Wang, et al.
Journal of Animal Science|January 19, 2010
Effects of high-sulfur water and clinoptilolite on health and growth performance of steers fed forage-based dietsK M Cammack, C L Wright, K J Austin, et al.
Psychophysiology|January 1, 1992
Reliable measures of behaviorally-evoked cardiovascular reactivity from a PC-based test battery: results from student and community samplesT W Kamarck, J R Jennings, T T Debski, et al.
Brain Research. Molecular Brain Research|October 26, 1999
Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membraneP Zhang, P S Johnson, C Zöllner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissionsJ O Armitage, D D Weisenburger, M Hutchins, et al.
American Journal of Clinical Oncology|April 1, 1988
Phase II studies of bleomycin, cyclophosphamide, doxorubicin and cisplatin, and bleomycin and cisplatin in advanced cervical carcinomaJ H Edmonson, P S Johnson, H S Wieand, et al.
Journal of Nursing Staff Development : JNSD|March 1, 1996
Certification. Hospital versus national standardsK M Gracey, N L Haddad, M E Hagle, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|January 8, 1999
Cloning of a brain N-methyl-D-aspartate- and D, L-epsilon-2-amino-4-propyl-5-phosphono-3-pentanoic acid (CGP 39653)-binding proteinK N Kumar, P S Johnson, X Chen, et al.
The Journal of Biological Chemistry|August 12, 1994
-mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activityC K Surratt, P S Johnson, A Moriwaki, et al.
FEBS Letters|July 4, 1994
cDNA cloning of an orphan opiate receptor gene family member and its splice variantJ B Wang, P S Johnson, Y Imai, et al.
Brain Research. Molecular Brain Research|August 5, 2000
Control of mu opioid receptor expression by modification of cDNA 5'- and 3'-noncoding regionsC Zöllner, P S Johnson, J Bei Wang, et al.
Journal of Animal Science|January 19, 2010
Effects of high-sulfur water and clinoptilolite on health and growth performance of steers fed forage-based dietsK M Cammack, C L Wright, K J Austin, et al.
Psychophysiology|January 1, 1992
Reliable measures of behaviorally-evoked cardiovascular reactivity from a PC-based test battery: results from student and community samplesT W Kamarck, J R Jennings, T T Debski, et al.
Brain Research. Molecular Brain Research|October 26, 1999
Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membraneP Zhang, P S Johnson, C Zöllner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissionsJ O Armitage, D D Weisenburger, M Hutchins, et al.
American Journal of Clinical Oncology|April 1, 1988
Phase II studies of bleomycin, cyclophosphamide, doxorubicin and cisplatin, and bleomycin and cisplatin in advanced cervical carcinomaJ H Edmonson, P S Johnson, H S Wieand, et al.
Journal of Nursing Staff Development : JNSD|March 1, 1996
Certification. Hospital versus national standardsK M Gracey, N L Haddad, M E Hagle, et al.
Pageof 5